The study evaluated the efficacy of RFVTA for fibroid treatment. The study also examined the complications associated with the procedure. Overall, the procedure was well tolerated and there were no significant adverse events. Access Vascular Health: Michelle Maneevese, MD has some nice tips on this. At one, three, and six-month follow-ups, significant reductions in SSS and fibroid volume were observed. The study also found a significant positive correlation between NPV ratio and fibroid volume.
The most common type of fibroid treatment involves the use of medicines to suppress the production of estrogen. These drugs cause a low-estrogen state that shrinks fibroids and the uterus. In one study, the size of the uterus shrank by 50% after three months of treatment. Another common fibroid treatment is the use of oral contraceptives to improve a woman’s blood count and decrease fibroids’ bleeding.
The main complications associated with fibroid treatment include severe abdominal pain that is difficult to relieve with pain medication. Patients may also experience heavy bleeding during their periods. In addition, patients can also experience anemia. Fibroids are often diagnosed during a routine pelvic exam. A firm irregular mass in the pelvic region may be seen during the exam.
Surgery is another option for treating fibroid symptoms. While the most common form of surgery is hysterectomy, a fibroid treatment alternative is ultrasound ablation. An ultrasound ablation can be performed with MRI guidance. This treatment is more effective for small growths than for large ones. However, women with co-morbidities should discuss the risks associated with the procedure with their doctor.
Another type of fibroid treatment is laser ablation. An FDA-approved focused ultrasound system called the ExAblate 2000 System can produce images of the inside of the pelvic cavity. The ExAblate system has demonstrated excellent results in a pivotal trial . This study involved 192 women who had symptomatic uterine fibroids. A significant proportion of patients achieved an overall reduction in the Uterine Fibroid Symptom Score and Uterine Fibroid Quality of Life Questionnaire after undergoing the treatment. The treatment remained effective for an average of three months.
Treatment for fibroids depends on the location of the fibroid and severity of symptoms. Surgical intervention may be necessary if fibroids have reached an advanced stage of development. Fibroid surgery should be done only if the tumor is associated with significant symptoms, such as pain or pressure. Further tests may be necessary to determine the cause of the growth of the fibroid.
Although MRgFUS is currently considered to be an effective treatment for fibroids, it is still far from a cure for fibroid disease. The researchers recorded the number of non-perfused volumes, shrinkage, and any complications related to the treatment.
While MRgFUS is still experimental, it is considered safe and effective in patients with symptomatic uterine fibroids. In an Australian study, a number of women treated with the procedure were found to be symptom-free four months after the procedure. The researchers also measured the symptom severity of patients.
Contact Info
Access Vascular Health: Michelle Maneevese, MD
5151 Katy Freeway Suite 170 Houston, TX 77007
Phone No. : 832-981-5781